Advisor Group Holdings, Inc. Relmada Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 5 shares of RLMD stock, worth $12. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$12
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RLMD
# of Institutions
56Shares Held
5.43MCall Options Held
0Put Options Held
0-
Driehaus Capital Management LLC Chicago, IL740KShares$1.92 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA619KShares$1.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$1.48 Million0.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD403KShares$1.05 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$942,9590.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $74.1M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...